Champions Oncology (CSBR) FCF Margin (2010 - 2026)
Champions Oncology (CSBR) posted quarterly FCF Margin of 16.17% for Q2 2026, down 7207.0% year-over-year from 0.23% in Q2 2025, and down 94.58% quarter-over-quarter from 8.31% in Q1 2026.
Champions Oncology (CSBR) FCF Margin (2010 - 2026) Analysis & Trends
Champions Oncology's FCF Margin history runs 17 years deep, the most recent figure standing at 16.17% for Q2 2026.
- In Q2 2026, FCF Margin fell 7207.0% year-over-year to 16.17%; the TTM figure through Apr 2026 stood at 8.47% (down 2076.0% YoY), while the FY2026 annual figure was 8.47%, down 2076.0% from the prior year.
- FCF Margin for Q2 2026 stood at 16.17%, down from 8.31% in the prior quarter.
- The five-year high for FCF Margin was 55.9% in Q2 2025, with the low at 37.09% in Q3 2023.
- The 5-year median for FCF Margin is 0.94% (2024), against an average of 0.39%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin soared 6885 bps in 2025, then plunged 7207 bps in 2026.
- Champions Oncology's FCF Margin stood at 18.78% in 2022, then plunged by 77 bps to 4.41% in 2023, then sank by 163 bps to 2.79% in 2024, then slumped by 313 bps to 11.55% in 2025, then tumbled by 40 bps to 16.17% in 2026.
- Business Quant data shows CSBR's FCF Margin at 16.17% in Q2 2026, 8.31% in Q1 2026, and 11.55% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | -16.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -16.17% |
| Jan 31, 2026 | -8.31% |
| Oct 31, 2025 | -11.55% |
| Jul 31, 2025 | 2.24% |
| Apr 30, 2025 | 55.90% |
| Jan 31, 2025 | 0.92% |
| Oct 31, 2024 | -2.79% |
| Jul 31, 2024 | 2.21% |
| Apr 30, 2024 | -12.95% |
| Jan 31, 2024 | -8.41% |
| Oct 31, 2023 | 4.41% |
| Jul 31, 2023 | -37.09% |
| Apr 30, 2023 | -11.11% |
| Jan 31, 2023 | 6.41% |
| Oct 31, 2022 | 18.78% |
| Jul 31, 2022 | -6.90% |
| Apr 30, 2022 | 2.25% |
| Jan 31, 2022 | 29.20% |
| Oct 31, 2021 | 5.62% |
| Jul 31, 2021 | -6.14% |